We are live on ! Find out more
ANGO icon

AngioDynamics

174 hedge funds and large institutions have $747M invested in AngioDynamics in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 58 increasing their positions, 67 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.88% less ownership

Funds ownership: 100.84%99.96% (-0.88%)

8% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 24

2% less funds holding

Funds holding: 177174 (-3)

8% less capital invested

Capital invested by funds: $813M → $747M (-$65.9M)

13% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 67

79% less call options, than puts

Call options by funds: $105K | Put options by funds: $503K

Holders
174
Holders Change
-3
Holders Change %
-1.69%
% of All Funds
3.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
58
Reduced
67
Closed
24
Calls
$105K
Puts
$503K
Net Calls
-$398K
Net Calls Change
+$450K
Name Holding Trade Value Shares
Change
Change in
Stake
FP
26
Foundry Partners
Minnesota
$6.82M -$263K -12,704 -4%
Principal Financial Group
27
Principal Financial Group
Iowa
$6.32M -$151K -7,318 -2%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$5.72M -$366K -17,690 -6%
Man Group
29
Man Group
United Kingdom
$5.71M -$4.79M -231,317 -45%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$5.67M +$741K +35,798 +15%
Prudential Financial
31
Prudential Financial
New Jersey
$5.29M -$73.2K -3,538 -1%
American Century Companies
32
American Century Companies
Missouri
$4.97M +$117K +5,641 +2%
Charles Schwab
33
Charles Schwab
California
$4.57M -$889K -42,940 -16%
Nordea Investment Management
34
Nordea Investment Management
Sweden
$4.44M +$246K +11,872 +6%
BCM
35
Bridgeway Capital Management
Texas
$3.87M -$317K -15,300 -7%
Morgan Stanley
36
Morgan Stanley
New York
$3.87M +$342K +16,524 +9%
MAM
37
Martingale Asset Management
Massachusetts
$3.51M +$136K +6,570 +4%
Axa
38
Axa
France
$3.4M -$366K -17,700 -9%
Loomis, Sayles & Company
39
Loomis, Sayles & Company
Massachusetts
$3.25M +$617K +29,840 +23%
HW
40
Hancock Whitney
Mississippi
$3.03M +$445K +21,505 +17%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$3.01M -$38.1K -1,842 -1%
Citadel Advisors
42
Citadel Advisors
Florida
$2.89M +$235K +11,365 +9%
TA
43
Teachers Advisors
New York
$2.54M +$445K +21,509 +21%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$2.45M +$20.8K +1,005 +0.8%
PPA
45
Parametric Portfolio Associates
Washington
$2.41M -$20.8K -1,006 -0.8%
TCIM
46
TIAA CREF Investment Management
New York
$2.39M -$641K -30,980 -21%
Goldman Sachs
47
Goldman Sachs
New York
$2.31M +$144K +6,966 +6%
Connor, Clark & Lunn Investment Management (CC&L)
48
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.21M -$921K -44,500 -29%
Two Sigma Advisers
49
Two Sigma Advisers
New York
$2.18M -$1.12M -54,223 -33%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$2.18M +$434K +20,978 +24%

ANGO Hedge Fund Activity: Q4 2018 in Review

174 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2018, worth a combined $747M — down 8.1% from $813M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of ANGO and 22 opened new positions — a net loss of 2 holders — while 67 trimmed existing stakes and 58 added.

The largest buyer was Victory Capital Management, adding an estimated $19.1M. The largest seller was Broadfin Capital, exiting entirely with an estimated $6.28M sold.

  • 174 institutional investors held AngioDynamics (ANGO) as of Q4 2018, down from 177 in Q3 2018.
  • Funds reported $747M of AngioDynamics stock for Q4 2018, down 8.1% quarter-over-quarter.
  • 22 funds opened new AngioDynamics positions in Q4 2018 and 24 closed out, a net change of -2 holders.
  • The largest AngioDynamics buyer in Q4 2018 was Victory Capital Management, an estimated $19.1M added.
  • The largest AngioDynamics seller in Q4 2018 was Broadfin Capital, an estimated $6.28M sold.

Based on aggregated 13F filings for Q4 2018.